OSE Immunotherapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	85	101	130	70	109	158
Market Cap Growth	-26.27%	-22.33%	85.55%	-36.14%	-30.57%	36.38%
Enterprise Value	92	89	103	95	114	155
Last Close Price	3.82	4.61	6.03	3.74	6.16	8.49
PE Ratio	-	-	4.19	-	-	-
PS Ratio	54.90	64.80	1.88	36.17	6.74	7.14
PB Ratio	2.92	3.45	2.46	3.51	3.78	3.92
P/TBV Ratio	-	-	2.46	3.53	3.80	3.93
P/FCF Ratio	-	-	3.24	-	-	-
P/OCF Ratio	-	-	3.24	-	-	-
EV/Sales Ratio	59.39	57.51	1.50	49.07	6.99	7.01
EV/EBITDA Ratio	-	-	2.84	-	-	-
EV/EBIT Ratio	-	-	2.86	-	-	-
EV/FCF Ratio	-3.91	-	2.58	-	-	-
Debt / Equity Ratio	1.06	1.06	0.72	1.99	1.37	0.78
Debt / EBITDA Ratio	-	-	1.03	-	-	-
Debt / FCF Ratio	-	-	0.95	-	-	-
Asset Turnover	0.02	0.02	0.81	0.03	0.19	0.27
Quick Ratio	1.19	1.19	3.29	1.40	1.97	2.36
Current Ratio	1.54	1.54	3.46	1.62	2.29	2.64
Return on Equity (ROE)	-66.82%	-66.82%	86.29%	-82.69%	-44.10%	-30.85%
Return on Assets (ROA)	-18.42%	-18.42%	26.54%	-16.53%	-11.93%	-10.45%
Return on Invested Capital (ROIC)	-66.55%	-66.55%	81.47%	-45.10%	-35.78%	-32.30%
Return on Capital Employed (ROCE)	-50.40%	-50.40%	42.20%	-36.30%	-24.50%	-19.50%
Earnings Yield	-33.24%	-28.16%	23.88%	-28.56%	-14.39%	-8.98%
FCF Yield	-27.65%	-23.43%	30.84%	-24.56%	-15.01%	-5.54%
Buyback Yield / Dilution	-3.76%	14.22%	-31.11%	-5.58%	-2.05%	-16.71%

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.